发明名称 |
Telocinobufagin (TCINO) in the Diagnosis and Pathogenesis of Preeclampsia, Traumatic Brain Injury and Acute Respiratory Distress Syndrome |
摘要 |
Certain embodiments are directed to methods of identifying patients with PE, TBI, or ARDS by detecting elevated levels of MBG, TCINO, and CINO and treating the same with anti-MBG agents. |
申请公布号 |
US2016299130(A1) |
申请公布日期 |
2016.10.13 |
申请号 |
US201615092715 |
申请日期 |
2016.04.07 |
申请人 |
PUSCHETT Jules B. |
发明人 |
PUSCHETT Jules B. |
分类号 |
G01N33/53 |
主分类号 |
G01N33/53 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for assessing patients for PE, TBI, or ARDS comprising (a) contacting a patient sample with a first binding reagent that specifically binds marinobufagenin (MBG) and a second binding reagent that specifically binds TCINO; (b) detecting and quantitating MBG-binding reagent complexes and TCINO-binding reagent complexes; and (c) classifying a patient as having PE, TBI, or ARDS if MBG, TCINO, or MBG and TCINO levels are elevated. |
地址 |
Houston TX US |